LIT vs XBI
Global X Lithium & Battery Tech ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.75% for LIT.
- • LIT pays a higher dividend yield (0.64%).
Side-by-side metrics
| Metric | LIT | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.64% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $1.77B | $10.73B |
YTD return | 11.66% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.37 | 1.10 |
P/E ratio | 24.41 | — |
Last price | $72.82 | $164.28 |
Inception | — | — |
Issuer | Global X | State Street |
LIT top holdings
| RIO | Rio Tinto PLC ADR | 20.01% |
| 002371.SZ | NAURA Technology Group Co Ltd Class A | 7.89% |
| 6752.T | Panasonic Holdings Corp | 6.19% |
| 6762.T | TDK Corp | 5.79% |
| ALB | Albemarle Corp | 4.64% |
| TSLA | Tesla Inc | 4.55% |
| 006400.KS | Samsung SDI Co Ltd | 4.07% |
| 300014.SZ | EVE Energy Co Ltd Class A | 3.75% |
| 300750.SZ | Contemporary Amperex Technology Co Ltd Class A | 3.66% |
| 373220.KS | LG Energy Solution Ltd | 3.22% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About LIT
LIT (Global X Lithium & Battery Tech ETF) is Full lithium cycle from mining to battery production. Managed by Global X, the fund carries $1.8B in assets under management, an expense ratio of 0.75%, a dividend yield of 0.64%. Its largest holding is Rio Tinto PLC ADR (RIO), which represents 20.0% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.